This meeting took place in 2013
Here are the related meetings in 2019:
Molecular Approaches to Vaccines and Immune Monitoring (J5)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Advancing Vaccines in the Genomics Era (T1)
Organizer(s) Bali Pulendran, Chris Wilson and Rino Rappuoli
October 31—November 4, 2013
Windsor Barra Hotel • Rio de Janeiro, Barra da Tijuca, Brazil
Discounted Abstract Deadline: Jun 27, 2013
Abstract Deadline: Jul 30, 2013
Scholarship Deadline: Jun 27, 2013
Discounted Registration Deadline: Aug 29, 2013
Sponsored by FAPERJ – Rio de Janeiro State Agency for Research Development. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.
Summary of Meeting:
A direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring.
View Meeting Program
A direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring.
View Meeting Program
Scholarships/Awards
Keystone Symposia Future of Science Fund Scholarship Recipients
Jacob D. GalsonUniversity of Oxford, UK
Elizabeth Ernestina Godoy-Lozano
Instituto Nacional de Salud Pública, Mexico
National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients
Juan C. AlvarezUniversidad de Antioquia, Colombia
Petter Brodin
Karolinska Institutet, Sweden
Brandon DeKosky
University of Kansas, USA
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Shaikh Meshbahuddin AhmadInternational Centre for Diarrhoeal Disease Research, ICDDR, Bangladesh
Oluwafemi David Ajayi
ABUAD Multi-System Hospital, Nigeria
Ardy Ardiansyah
Universitas Bakrie, Indonesia
Ken Odhiambo Awuondo
KEMRI-Wellcome Trust Research Laboratories, Kilifi-Kenya, Kenya
Adeleye Solomon Bakarey
University of Ibadan, Nigeria
Rafael Polidoro Alves Barbosa
ICB, Universidade Federal de Minas Gerais, Brazil
Yonas Bekele Feyissa
Karolinska Institutet, Sweden
Fabiana Bigi
Institute of Biotechnology, Argentina
Jordana G. A. Coelho-dos-Reis
Fiocruz, Brazil
Bertha Espinoza
Ins, Investigaciones Biomedicas - UNAM, Mexico
Laura Emilia Esteban
Universidad Nacional de Quilmes, Argentina
Gustavo Rocha Garcia
University of São Paulo, Brazil
Darien Garcia Diaz
Center for Genetic Engineering and Biotechnology, Cuba
Anwar Hashem
King Abdulaziz University, Saudi Arabia
Shivaji K. Jadhav
Lilac Insights, India
Madhu Khanna
University of Delhi, India
Zeleke Mekonnen Kurmane
Jimma University, Ethiopia
Gloria Ivy Mensah
Noguchi Memorial Institute for Medical Research, Ghana
Clement Adebajo Meseko
National Veterinary Resesrch Institute, Vom, Nigeria
Eliane Namie Miyaji
Instituto Butantan, Brazil
Bolanle Olufunke Priscilla Musa
Ahmadu Bello University Teaching Hospital, Nigeria
Faith Osier
KEMRI-CGMRC, Kenya
Victor Riitho
International Livestock Research Institute, Kenya
Vijaya Satchidanandam
Indian Institute of Science, India
Angamuthu Selvapandiyan
Institute of Molecular Medicine, India
Somporn Srifuengfung
Mahidol University, Thailand
Phonphimon Wongthida
National Center of Genetic Engineering and Biotechnology, Thailand
